Skip to content
Dose Brief
Menu

Evidence & access

Is compounded semaglutide legit? What to check

Compounded semaglutide: 503A and 503B pharmacies, LegitScript, FDA rules, and the checks to make before choosing a provider.

By The Dose Brief Desk, News Editor

Updated · Editorial standards

In this brief

Checking compounded semaglutide means looking at both the pharmacy and whether the particular prescription meets applicable compounding requirements. Compounding is a legitimate, long-standing part of pharmacy — and it's also an area where quality varies more than with an FDA-approved product. Here's how to tell the difference without a pharmacy degree. The legal ground under it has also shifted: the shortage that made large-scale compounding permissible has ended for both molecules, which changes who may still compound them and on what terms. That status, with the dates, is in is compounded semaglutide still legal?.

What compounding actually is

Compounding prepares a medication for a particular need rather than dispensing an approved manufactured product. It may be lawful when the applicable federal and state conditions are met, but compounded drugs are not FDA-approved. FDA does not verify their safety, effectiveness or quality before marketing1. Pharmacy quality controls matter; they do not replace drug approval or remove restrictions on making copies4.

503A vs 503B — the two kinds of compounder

Under federal law there are two categories. A 503A pharmacy compounds patient-specific prescriptions, typically at a traditional or telehealth-affiliated pharmacy scale. A 503B outsourcing facility registers with the FDA, is inspected on a risk-based schedule, and follows stricter manufacturing standards so it can produce larger batches1. Neither status makes the compounded product FDA-approved. FDA registration and inspection are oversight facts, not permission to compound any GLP-1 copy from bulk ingredients45.

Where the shortage rules fit

Much of the compounded GLP-1 market grew during the period when brand-name semaglutide was on the FDA shortage list, which gave compounders more latitude to make copies2. As those shortages resolved, that latitude narrowed and regulatory attention increased. That doesn't make compounded semaglutide illegitimate — but it does mean the landscape is shifting, so a provider's compliance posture matters more than ever. The fuller story is in GLP-1 shortages and supply.

The checks that matter

Verify the dispensing pharmacy, the prescriber and any claimed certification. A current LegitScript certification can be one screening check, but it is not FDA drug approval, a guarantee of quality or a determination that your particular prescription meets compounding law145.

Does the provider name its 503A or 503B pharmacy partner, or at least explain its sourcing? For a sense of what a full answer looks like, Pallas Health names six dispensing pharmacies and publishes two prescribers' NPI numbers with a link to the federal registry to check them — the pharmacy list even explains the 503A/503B split rather than leaving you to work it out. That is unusual; most providers name nobody, and Oak is a plain example of what that looks like — its pages say only "Oak's contracted pharmacies" and "independent licensed physicians and nurse practitioners contracted through Oak's medical group partners", with no pharmacy, no clinician and no NPI published anywhere, while its own Terms, Privacy policy and checkout name three different operating companies between them.

Is there a licensed clinician involved in prescribing, with a real health intake rather than a rubber-stamp form? Is your state served, and is licensing information available? And is the price stable and disclosed, or a teaser that hides the real cost? Our compounded semaglutide price and supply ranking shows which tracked providers currently pass that last test. Clear answers help you investigate; they do not by themselves establish a product’s lawful status or suitability for you.

Red flags

Some signals should stop you. A provider that will not show you what it sells before you pay is near the top of the list: Lighter You publishes no product pages at all and gates its catalog behind a login, so the only way to learn what molecule, dose or format you are buying is to complete an intake — at which point you have already been charged. It is not a front, and it names four pharmacies with street addresses, which is more than most. But you cannot vet what you cannot read. No named pharmacy and no accreditation. Claims that a compounded product is 'FDA-approved' — it isn't, and saying so is a misrepresentation1. 'Research-only,' gray-market, or unusually additive-laden formulations — this is exactly the category retatrutide falls into, since it has no FDA-approved reference product at all and, unlike semaglutide, cannot legally be compounded under federal law by any pharmacy, licensed or not. No clinician contact. And prices so far below the market that you should ask how the provider can possibly source safely at that number. The same molecule still carries the FDA's boxed warning about thyroid C-cell tumors and its contraindications — see what that warning actually means — so a provider that skips real screening is cutting a corner that matters3. A provider that also skips real GI screening is the same corner behind the ongoing GLP-1 gastroparesis litigation, which is worth understanding regardless of which pharmacy you use.

The bottom line

A named, appropriately licensed pharmacy and clinical oversight are necessary checks, not a complete answer. Ask why a compounded prescription is appropriate for you and how the applicable requirements are met. Use the provider checklist, read the brand-versus-compound comparison, and consult our provider briefs for disclosed costs and service details. None of those checks makes a compounded preparation FDA-approved15.

Frequently asked questions

Is compounded semaglutide FDA-approved?

No. FDA does not approve compounded semaglutide or verify its safety, effectiveness and quality before marketing. Whether a particular prescription may lawfully be compounded depends on the applicable requirements; a pharmacy license or certification does not settle that question.

What's the difference between a 503A and 503B pharmacy?

A 503A pharmacy compounds patient-specific prescriptions; a 503B outsourcing facility registers with the FDA, is inspected, and follows stricter manufacturing standards for larger batches. Neither makes an FDA-approved product, but a 503B operates under more oversight.

What should make me walk away from a provider?

No named pharmacy or accreditation, claims that the compounded product is FDA-approved, no clinician involvement or real health screening, 'research-only' framing, or prices so far below market that safe sourcing seems implausible.

References

  1. U.S. Food and Drug Administration (2024). Compounding and the FDA: Questions and Answers. FDA. https://www.fda.gov/drugs/human-drug-compounding/compounding-and-fda-questions-and-answers
  2. U.S. Food and Drug Administration (2025). FDA Drug Shortages database. FDA. https://www.accessdata.fda.gov/scripts/drugshortages/default.cfm
  3. U.S. Food and Drug Administration (2024). Wegovy (semaglutide) injection — Drugs@FDA prescribing information. FDA. https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=215256
  4. U.S. Food and Drug Administration (2026). FDA clarifies policies for compounders as national GLP-1 supply begins to stabilize. FDA. https://www.fda.gov/drugs/drug-alerts-and-statements/fda-clarifies-policies-compounders-national-glp-1-supply-begins-stabilize
  5. U.S. Food and Drug Administration (2026). Is It Really FDA Approved?. FDA. https://www.fda.gov/consumers/consumer-updates/it-really-fda-approved

Medical disclaimer: This content is for general educational purposes only and is not medical advice, diagnosis, or treatment. Always consult a licensed healthcare professional before starting, stopping, or changing any treatment.